Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Department of Medical Oncology, JiLin Province People's Hospital, Changchun City, JiLin Province, 130021, China.
Bioengineered. 2022 Mar;13(3):6464-6475. doi: 10.1080/21655979.2022.2031385.
Numerous studies have clarified the involvement of circular RNAs (circRNAs) in modulating malignant behavior of non-small cell lung cancer (NSCLC), while the concrete mechanism is not completely elucidated. The aim of the study was to figure out the latent functions and molecular mechanisms of circRNA Eps15-homology domain containing protein 2 (EHD2) on NSCLC proliferation, glycolysis and autophagy. The results clarified in NSCLC elevated expression of circEHD2 and declined expression of microRNA (miR)-3186-3p. Repressive circEHD2 or enhancive miR-3186-3p facilitated cell apoptosis rate and autophagy substrates LC3BII and Beclin-1, but curbed the colony-formation and DNA replication ability of NSCLC, glucose consumption, lactic acid production, glycolytic rate-limiting enzyme HK-2 and glutamine hydrolase GLS1 and P62, while overexpressed circEHD2 was adverse. Meanwhile, the impacts of repressive and elevated circEHD2 on NSCLC were turned around via reduced miR-3186-3p or forkhead box k1 (FOXK1) separately. Mechanically, FOXK1 was augmented via circEHD2's competitive integration of miR-3186-3p. Depressive circEHD2 refrained NSCLC tumor growth, which was accelerated via enhancive one. All in all, circEHD2 accelerates the proliferation and glycolysis of NSCLC, but refrains autophagy and apoptosis via strengthening FOXK1 via the adsorption of miR-3186-3p, which is supposed to be a latent molecular target for NSCLC therapy later.
大量研究阐明了环状 RNA(circRNA)在调节非小细胞肺癌(NSCLC)恶性行为中的作用,但其具体机制尚不完全清楚。本研究旨在探讨 circRNA Eps15 同源结构域包含蛋白 2(EHD2)在 NSCLC 增殖、糖酵解和自噬中的潜在功能和分子机制。结果表明,circEHD2 在 NSCLC 中表达升高,而 microRNA(miR)-3186-3p 表达降低。抑制 circEHD2 或增强 miR-3186-3p 可促进 NSCLC 细胞凋亡率和自噬底物 LC3BII 和 Beclin-1 的表达,但抑制 NSCLC 的集落形成和 DNA 复制能力、葡萄糖消耗、乳酸生成、糖酵解限速酶 HK-2 和谷氨酰胺水解酶 GLS1 和 P62 的表达,而过表达 circEHD2 则相反。同时,通过降低 miR-3186-3p 或叉头框 k1(FOXK1),分别逆转抑制性和上调 circEHD2 对 NSCLC 的影响。机制上,circEHD2 通过竞争性结合 miR-3186-3p 增强了 FOXK1 的表达。抑制性 circEHD2 抑制 NSCLC 肿瘤生长,而增强性 circEHD2 则加速其生长。总之,circEHD2 通过增强 FOXK1 促进 NSCLC 的增殖和糖酵解,但通过吸附 miR-3186-3p 抑制自噬和凋亡,这可能是 NSCLC 治疗的潜在分子靶点。